Warning: This security is no longer trading.
defunct
Gemphire Therapeutics Inc. (GEMP): Price and Financial Metrics
GEMP Price/Volume Stats
| Current price | $7.50 | 52-week high | $8.50 |
| Prev. close | $0.30 | 52-week low | $0.24 |
| Day low | $7.26 | Volume | 7,640 |
| Day high | $8.50 | Avg. volume | 127,174 |
| 50-day MA | $0.34 | Dividend yield | N/A |
| 200-day MA | $0.71 | Market Cap | 111.54M |
GEMP Stock Price Chart Interactive Chart >
Gemphire Therapeutics Inc. (GEMP) Company Bio
Gemphire Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of dyslipidemia cardiovascular disease. The company was founded in 2008 and is headquartered in Northville, Michigan.
GEMP Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | -77.10% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | 0.00% |
Loading social stream, please wait...